Respiratory Medicine
Volume 104, Issue 5 , Pages 697-704 , May 2010

Economic implications of comorbid conditions among Medicaid beneficiaries with COPD

  • Pei-Jung Lin

      Affiliations

    • Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 636 4616; fax: +1 617 636 5560.
    • ,
  • Fadia T. Shaya

      Affiliations

    • Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    • ,
  • Steven M. Scharf

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, University of Maryland Sleep Disorders Center, Baltimore, MD 21201, USA

Received 22 June 2009 ,Accepted 15 November 2009.

References 

  1. NHLBI. Morbidity and Mortality chart book: chart book on cardiovascular, lung, and blood diseases; 2007.
  2. Centers for Disease Control and Prevention . Leading causes of death. http://www.cdc.gov/nchs/FASTATS/lcod.htm2008;[accessed 1.03.09]
  3. van Manen JG, Bindels PJ, van der Zee JS, Ij Cj, Bottema BJ, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol. 2001;54(3):287–293
  4. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case–control study in a health maintenance organization. Arch Intern Med. 2000;160(17):2653–2658
  5. Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63(6):487–492
  6. Vilkman S, Keistinen T, Tuuponen T, Kivela SL. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration. 1997;64(4):281–284
  7. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132(6):1748–1755
  8. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD – its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33–37
  9. Wijnhoven HA, Kriegsman DM, Hesselink AE, de Haan M, Schellevis FG. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003;97(5):468–475
  10. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257
  11. Krachman S, Minai OA, Scharf SM. Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc. 2008;5(4):536–542
  12. Shaya FT, Lin PJ, Aljawadi MH, Scharf SM. Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome. Sleep Breath. 2009;13(4):315–316
  13. Shaya FT, Dongyi D, Akazawa MO, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 2008;134(1):14–19
  14. Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a medicare advantage population. J Manag Care Pharm. 2008;14(2):176–185
  15. Grasso ME, Weller WE, Shaffer TJ, Diette GB, Anderson GF. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(1):133–138
  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383
  17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619
  18. Mapel DW, Frost FJ, Hurley JS, et al. An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm. 2006;12(6):457–465
  19. Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Economic burden prior to COPD diagnosis: a matched case–control study in the United States. Respir Med. 2008;102(12):1744–1752
  20. NHLBI . Who is at risk for high blood pressure?. http://www.nhlbi.nih.gov/health/dci/Diseases/Hbp/HBP_WhoIsAtRisk.html2008;[accessed 1.03.09]
  21. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128(4):2005–2011
  22. Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD resource network needs assessment survey. Am J Med. 2005;118(12):1415
  23. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–2075
  24. Mapel DW, Robinson SB, Dastani HB, Shah H, Phillips AL, Lydick E. The direct medical costs of undiagnosed chronic obstructive pulmonary disease. Value Health. 2008;11(4):628–636

☆ An abstract of this manuscript was presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting, May 16–20, 2009.

PII: S0954-6111(09)00373-4

doi: 10.1016/j.rmed.2009.11.009

Respiratory Medicine
Volume 104, Issue 5 , Pages 697-704 , May 2010

Article Tools